If you’d like to help transform the lives of Australians helping them to become healthier in an evidence-based way as well as support the healthcare system by reducing the use of costly medications and hospitalisations associated with diabetes, all while reflecting empathy along the way, please email us below.
As seen in
Although there is no universally agreed upon definition for the reversal of type 2 diabetes, Diversa uses HbA1c to assist in defining diabetes and pre-diabetes reversal.
Type 2 diabetes reversal is when a patient who previously had an HbA1c in the diabetic range (>6.5%) returning an HbA1c in the non-diabetic range (<6.4%) (along with the absence of medications used to manage diabetes). Pre-diabetes reversal is when a patient who previously had an HbA1c in the pre-diabetic range (5.7-6.4%) returning an HbA1c to the non pre-diabetic range (less than 5.7%).
It is important to recognise that although not everybody may be able to completely reverse type 2 diabetes, partial reversal, the reduction of medication dosages, along with the simultaneous lowering of HbA1c, will unquestionably achieve a better quality of life and improve health outcomes for those living with type 2 diabetes.
Want to know more?
Our expert team is ready to answer any questions you may have.